← Back to Patent Explorer
US4563489A Expired / Lapsed US ⏱️ 0.0 years remaining

Biodegradable organic polymer delivery system for bone morphogenetic protein

Assignee: University of California
•
Filing: 1984-02-10
•
Granted: 1986-01-07
•
Expires: 2004-02-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed is a biodegradable polylactic acid polymer delivery system for delivery of bone morphogenic protein (BMP) to induce formation of new bone in viable tissue. The delivery composition is substantially pure BMP in combination with a biodegradable polylactic acid polymer and it is prepared by admixing the BMP with the biodegradable polymer. The composition is implanted in viable tissue where the BMP is slowly released and induces formation of new bone.

Inventors

  • 👤 Marshall R. Urist

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 18:59
CPC Classifications
A; A61; A61L; A61L27/00; A61L27/14; A61L27/22; A61L27/227; A61K; A61K9/00; A61K9/20; A61K9/2004; A61K9/2022; A61K9/2031; A61K9/204; A61L27/26; Y; Y10; Y10S; Y10S623/00; Y10S623/915

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 13 words
A composition comprising substantially pure BMP and physiologically acceptable, biodegradable polylactic acid polymer.
Claim 2
Dependent Claim 13 words
A composition comprising substantially pure BMP and physiologically acceptable, biodegradable polylactic acid polymer.
Claim 3
Dependent Claim 24 words
A composition comprising substantially pure BMP and a physiologically acceptable, biodegradable organic polymer selected from polylactic acid, polylactide, polyglycollic acid, polyglactin or polyglactic acid.
Claim 4
Dependent Claim 24 words
A composition comprising substantially pure BMP and a physiologically acceptable, biodegradable organic polymer selected from polylactic acid, polylactide, polyglycollic acid, polyglactin or polyglactic acid.
Claim 5
Dependent Claim 27 words
A delivery composition for delivering BMP to induce formation of new bone in viable tissue comprising substantially pure BMP and a physiologically acceptable, biodegradable polylactic acid polymer.
Claim 6
Dependent Claim 27 words
A delivery composition for delivering BMP to induce formation of new bone in viable tissue comprising substantially pure BMP and a physiologically acceptable, biodegradable polylactic acid polymer.
Claim 7
Dependent Claim 36 words
The delivery composition according to claim 3 to induce formation of new bone in viable tissue wherein the weight ratio of BMP to polymer is at least about 0.05 parts BMP to about 20 parts polymer.
Claim 8
Dependent Claim 22 words
The delivery composition according to claim 4 wherein the ratio is at least about 0.1 parts BMP to about 20 parts polymer.
Claim 9
Dependent Claim 24 words
The delivery composition of claim 5 wherein said weight ratio is in the range of up to 10 parts BMP to 20 parts polymer.
Claim 10
Dependent Claim 13 words
The delivery composition of claim 4 including in said composition a radioopacifying agent.
Claim 11
Dependent Claim 12 words
The delivery composition of claim 4 including in said composition an antibiotic.
Claim 12
Dependent Claim 37 words
A delivery composition for delivering BMP to induce formation of new bone in viable tissue comprising substantially pure BMP and a physiologically acceptable, biodegradable organic polymer selected from polylactic acid, polylactide, polyglycollic acid, polyglactin or polyglactic acid.
Claim 13
Dependent Claim 37 words
A delivery composition for delivering BMP to induce formation of new bone in viable tissue comprising substantially pure BMP and a physiologically acceptable, biodegradable organic polymer selected from polylactic acid, polylactide, polyglycollic acid, polyglactin or polyglactic acid.
Claim 14
Independent Claim 97 words
The method of preparing a delivery composition for delivering BMP to induce formation of new bone in viable tissue comprising the step of dissolving physiologically acceptable, biodegradable polylactic polymer in a solvent to form a solution, admixing the solution and BMP to form a dispersion, adding a second solvent to the dispersion which causes the precipitation of the polymer and forms a composite of said polymer and said BMP, and removing the solvents from said composite to form said composition, the weight ratio of BMP and polymer being at least 0.05 parts BMP to 20 parts polymer.
Claim 15
Independent Claim 97 words
The method of preparing a delivery composition for delivering BMP to induce formation of new bone in viable tissue comprising the step of dissolving physiologically acceptable, biodegradable polylactic polymer in a solvent to form a solution, admixing the solution and BMP to form a dispersion, adding a second solvent to the dispersion which causes the precipitation of the polymer and forms a composite of said polymer and said BMP, and removing the solvents from said composite to form said composition, the weight ratio of BMP and polymer being at least 0.05 parts BMP to 20 parts polymer.
Claim 16
Independent Claim 46 words
The method of inducing formation of new bone in viable tissue comprising implanting in said viable tissue a delivery composition comprising BMP and a physiologically acceptable, biodegradable polylactic acid polymer wherein the weight ratio is at least about 0.05 parts BMP to about 20 parts polymer.
Claim 17
Independent Claim 46 words
The method of inducing formation of new bone in viable tissue comprising implanting in said viable tissue a delivery composition comprising BMP and a physiologically acceptable, biodegradable polylactic acid polymer wherein the weight ratio is at least about 0.05 parts BMP to about 20 parts polymer.
Claim 18
Dependent Claim 22 words
A method according to claim 11 wherein the weight ratio is at least about 0.1 parts BMP to about 20 parts polymer.
Claim 19
Dependent Claim 22 words
A method according to claim 12 wherein the weight ratio is at least about 0.1 parts BMP to about 20 prts polymer.

References Cited (Backward Citations)

US4428082A Cited
US4394370A Cited
US4430760A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-01-06 1989-07-08 1990-01-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-01-06 1993-07-08 1994-01-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-01-06 1997-07-08 1998-01-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag